 | • レポートコード：QYR9NV01738 • 出版社/出版日：QYResearch / 2019年11月12日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・ヘルスケア |
| Single User | ￥525,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,050,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、バイオシミラーの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、組換え非グリコシル化タンパク質（インスリン、rHGH、インターフェロン）、グリコシル化（mAb、EPO）、ペプチド（グルカゴン、カルシトニン）、ペプチド（グルカゴン、カルシトニン）に、用途別には、腫瘍学、血液疾患にセグメント区分し、バイオシミラーの世界市場を分析しました。 ・エグゼクティブ・サマリー ・バイオシミラーの世界市場概要 ・バイオシミラーの製造コスト構成分析 ・バイオシミラーの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・バイオシミラーの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・バイオシミラーのセグメント分析（種類別） （組換え非グリコシル化タンパク質（インスリン、rHGH、インターフェロン）、グリコシル化（mAb、EPO）、ペプチド（グルカゴン、カルシトニン）、ペプチド（グルカゴン、カルシトニン）） ・バイオシミラーのセグメント分析（用途別） （腫瘍学、血液疾患） ・バイオシミラーの主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Pfizer、Sandoz International GmbH、Teva Pharmaceuticals Industries、Amgen Inc、Biocon、Dr. Reddy’s Laboratories、F. Hoffmann-La Roche、Celltrion、Samsung Bioepis、） ・バイオシミラーの市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global Biosimilars market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Biosimilars volume and value at global level, regional level and company level. From a global perspective, this report represents overall Biosimilars market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Biosimilars in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Biosimilars manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Pfizer
Sandoz International GmbH
Teva Pharmaceuticals Industries
Amgen Inc
Biocon
Dr. Reddy’s Laboratories
F. Hoffmann-La Roche
Celltrion
Samsung Bioepis
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
Peptides (Glucagon, Calcitonin)
Segment by Application
Oncology
Blood Disorders
Table of Contents
Executive Summary
1 Industry Overview of Biosimilars
1.1 Definition of Biosimilars
1.2 Biosimilars Segment by Type
1.2.1 Global Biosimilars Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
1.2.3 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
1.2.4 Peptides (Glucagon, Calcitonin)
1.3 Biosimilars Segment by Applications
1.3.1 Global Biosimilars Consumption Comparison by Applications (2014-2025)
1.3.2 Oncology
1.3.3 Blood Disorders
1.4 Global Biosimilars Overall Market
1.4.1 Global Biosimilars Revenue (2014-2025)
1.4.2 Global Biosimilars Production (2014-2025)
1.4.3 North America Biosimilars Status and Prospect (2014-2025)
1.4.4 Europe Biosimilars Status and Prospect (2014-2025)
1.4.5 China Biosimilars Status and Prospect (2014-2025)
1.4.6 Japan Biosimilars Status and Prospect (2014-2025)
1.4.7 Southeast Asia Biosimilars Status and Prospect (2014-2025)
1.4.8 India Biosimilars Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Biosimilars
2.3 Manufacturing Process Analysis of Biosimilars
2.4 Industry Chain Structure of Biosimilars
3 Development and Manufacturing Plants Analysis of Biosimilars
3.1 Capacity and Commercial Production Date
3.2 Global Biosimilars Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Biosimilars
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Biosimilars Production and Capacity Analysis
4.2 Biosimilars Revenue Analysis
4.3 Biosimilars Price Analysis
4.4 Market Concentration Degree
5 Biosimilars Regional Market Analysis
5.1 Biosimilars Production by Regions
5.1.1 Global Biosimilars Production by Regions
5.1.2 Global Biosimilars Revenue by Regions
5.2 Biosimilars Consumption by Regions
5.3 North America Biosimilars Market Analysis
5.3.1 North America Biosimilars Production
5.3.2 North America Biosimilars Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Biosimilars Import and Export
5.4 Europe Biosimilars Market Analysis
5.4.1 Europe Biosimilars Production
5.4.2 Europe Biosimilars Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Biosimilars Import and Export
5.5 China Biosimilars Market Analysis
5.5.1 China Biosimilars Production
5.5.2 China Biosimilars Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Biosimilars Import and Export
5.6 Japan Biosimilars Market Analysis
5.6.1 Japan Biosimilars Production
5.6.2 Japan Biosimilars Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Biosimilars Import and Export
5.7 Southeast Asia Biosimilars Market Analysis
5.7.1 Southeast Asia Biosimilars Production
5.7.2 Southeast Asia Biosimilars Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Biosimilars Import and Export
5.8 India Biosimilars Market Analysis
5.8.1 India Biosimilars Production
5.8.2 India Biosimilars Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Biosimilars Import and Export
6 Biosimilars Segment Market Analysis (by Type)
6.1 Global Biosimilars Production by Type
6.2 Global Biosimilars Revenue by Type
6.3 Biosimilars Price by Type
7 Biosimilars Segment Market Analysis (by Application)
7.1 Global Biosimilars Consumption by Application
7.2 Global Biosimilars Consumption Market Share by Application (2014-2019)
8 Biosimilars Major Manufacturers Analysis
8.1 Pfizer
8.1.1 Pfizer Biosimilars Production Sites and Area Served
8.1.2 Pfizer Product Introduction, Application and Specification
8.1.3 Pfizer Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Sandoz International GmbH
8.2.1 Sandoz International GmbH Biosimilars Production Sites and Area Served
8.2.2 Sandoz International GmbH Product Introduction, Application and Specification
8.2.3 Sandoz International GmbH Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Teva Pharmaceuticals Industries
8.3.1 Teva Pharmaceuticals Industries Biosimilars Production Sites and Area Served
8.3.2 Teva Pharmaceuticals Industries Product Introduction, Application and Specification
8.3.3 Teva Pharmaceuticals Industries Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Amgen Inc
8.4.1 Amgen Inc Biosimilars Production Sites and Area Served
8.4.2 Amgen Inc Product Introduction, Application and Specification
8.4.3 Amgen Inc Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Biocon
8.5.1 Biocon Biosimilars Production Sites and Area Served
8.5.2 Biocon Product Introduction, Application and Specification
8.5.3 Biocon Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Dr. Reddy’s Laboratories
8.6.1 Dr. Reddy’s Laboratories Biosimilars Production Sites and Area Served
8.6.2 Dr. Reddy’s Laboratories Product Introduction, Application and Specification
8.6.3 Dr. Reddy’s Laboratories Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 F. Hoffmann-La Roche
8.7.1 F. Hoffmann-La Roche Biosimilars Production Sites and Area Served
8.7.2 F. Hoffmann-La Roche Product Introduction, Application and Specification
8.7.3 F. Hoffmann-La Roche Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Celltrion
8.8.1 Celltrion Biosimilars Production Sites and Area Served
8.8.2 Celltrion Product Introduction, Application and Specification
8.8.3 Celltrion Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Samsung Bioepis
8.9.1 Samsung Bioepis Biosimilars Production Sites and Area Served
8.9.2 Samsung Bioepis Product Introduction, Application and Specification
8.9.3 Samsung Bioepis Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
9 Development Trend of Analysis of Biosimilars Market
9.1 Global Biosimilars Market Trend Analysis
9.1.1 Global Biosimilars Market Size (Volume and Value) Forecast 2019-2025
9.2 Biosimilars Regional Market Trend
9.2.1 North America Biosimilars Forecast 2019-2025
9.2.2 Europe Biosimilars Forecast 2019-2025
9.2.3 China Biosimilars Forecast 2019-2025
9.2.4 Japan Biosimilars Forecast 2019-2025
9.2.5 Southeast Asia Biosimilars Forecast 2019-2025
9.2.6 India Biosimilars Forecast 2019-2025
9.3 Biosimilars Market Trend (Product Type)
9.4 Biosimilars Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Biosimilars Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Biosimilars
Table Global Biosimilars Production (K MT) Growth Rate Comparison by Types (2014-2025)
Figure Global Biosimilars Production Market Share by Types in 2018
Figure Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Product Picture
Figure Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Product Picture
Figure Peptides (Glucagon, Calcitonin) Product Picture
Table Global Biosimilars Consumption (K MT) Comparison by Applications (2014-2025)
Figure Global Biosimilars Consumption Market Share by Applications in 2018
Figure Oncology
Figure Blood Disorders
Figure Global Biosimilars Revenue (Million USD) (2014-2025)
Figure Global Biosimilars Production (K MT) (2014-2025)
Figure North America Biosimilars Market Size (Million USD) (2014-2025)
Figure Europe Biosimilars Market Size (Million USD) (2014-2025)
Figure China Biosimilars Market Size (Million USD) (2014-2025)
Figure Japan Biosimilars Market Size (Million USD) (2014-2025)
Figure Southeast Asia Biosimilars Market Size (Million USD) (2014-2025)
Figure India Biosimilars Market Size (Million USD) (2014-2025)
Table Biosimilars Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Biosimilars in 2018
Figure Manufacturing Process Analysis of Biosimilars
Figure Industry Chain Structure of Biosimilars
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Biosimilars Manufacturing Plants Distribution
Table Biosimilars Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Biosimilars Capacity (K MT) of Major Manufacturers (2014-2019)
Table Biosimilars Production (K MT) of Major Manufacturers (2014-2019)
Table Biosimilars Production Market Share of Major Manufacturers (2014-2019)
Figure Biosimilars Production Share by Manufacturers in 2018
Table Biosimilars Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Biosimilars Revenue Market Share of Major Manufacturers (2014-2019)
Figure Biosimilars Revenue Share by Manufacturers in 2018
Table Biosimilars Average Price (USD/MT) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Biosimilars Production by Regions 2014-2019 (K MT)
Table Global Biosimilars Production Market Share by Regions 2014-2019
Figure Global Biosimilars Production Market Share by Regions in 2018
Table Global Biosimilars Revenue by Regions 2014-2019 (Million USD)
Table Global Biosimilars Revenue Market Share by Regions 2014-2019
Figure Global Biosimilars Revenue Market Share by Regions in 2018
Table Global Biosimilars Consumption by Regions 2014-2019 (K MT)
Table Global Biosimilars Consumption Market Share by Regions 2014-2019
Figure North America Biosimilars Production Growth Rate 2014-2019 (K MT)
Figure North America Biosimilars Revenue Growth Rate 2014-2019 (Million USD)
Table North America Biosimilars Production, Consumption Import and Export (K MT)
Figure Europe Biosimilars Production Growth Rate 2014-2019 (K MT)
Figure Europe Biosimilars Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Biosimilars Production, Consumption Import and Export (K MT)
Figure China Biosimilars Production Growth Rate 2014-2019 (K MT)
Figure China Biosimilars Revenue Growth Rate 2014-2019 (Million USD)
Table China Biosimilars Production, Consumption Import and Export (K MT)
Figure Japan Biosimilars Production Growth Rate 2014-2019 (K MT)
Figure Japan Biosimilars Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Biosimilars Production, Consumption Import and Export (K MT)
Figure Southeast Asia Biosimilars Production Growth Rate 2014-2019 (K MT)
Figure Southeast Asia Biosimilars Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Biosimilars Production, Consumption Import and Export (K MT)
Figure India Biosimilars Production Growth Rate 2014-2019 (K MT)
Figure India Biosimilars Revenue Growth Rate 2014-2019 (Million USD)
Table India Biosimilars Production, Consumption Import and Export (K MT)
Figure Global Consumption Biosimilars Market Share by Application (2014-2019)
Figure Global Value (Consumption) Biosimilars Market Share by Application (2014-2019)
Table Pfizer Biosimilars Production Sites and Area Served
Table Pfizer Biosimilars Product Introduction, Application and Specification
Table Pfizer Biosimilars Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Pfizer Biosimilars Production Growth Rate (2014-2019)
Table Pfizer Biosimilars Production Market Share (2014-2019)
Figure Pfizer Biosimilars Revenue Market Share (2014-2019)
Table Pfizer Biosimilars Main Business and Markets Served
Table Sandoz International GmbH Biosimilars Production Sites and Area Served
Table Sandoz International GmbH Biosimilars Product Introduction, Application and Specification
Table Sandoz International GmbH Biosimilars Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Sandoz International GmbH Biosimilars Production Growth Rate (2014-2019)
Table Sandoz International GmbH Biosimilars Production Market Share (2014-2019)
Figure Sandoz International GmbH Biosimilars Revenue Market Share (2014-2019)
Table Sandoz International GmbH Biosimilars Main Business and Markets Served
Table Teva Pharmaceuticals Industries Biosimilars Production Sites and Area Served
Table Teva Pharmaceuticals Industries Biosimilars Product Introduction, Application and Specification
Table Teva Pharmaceuticals Industries Biosimilars Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Teva Pharmaceuticals Industries Biosimilars Production Growth Rate (2014-2019)
Table Teva Pharmaceuticals Industries Biosimilars Production Market Share (2014-2019)
Figure Teva Pharmaceuticals Industries Biosimilars Revenue Market Share (2014-2019)
Table Teva Pharmaceuticals Industries Biosimilars Main Business and Markets Served
Table Amgen Inc Biosimilars Production Sites and Area Served
Table Amgen Inc Biosimilars Product Introduction, Application and Specification
Table Amgen Inc Biosimilars Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Amgen Inc Biosimilars Production Growth Rate (2014-2019)
Table Amgen Inc Biosimilars Production Market Share (2014-2019)
Figure Amgen Inc Biosimilars Revenue Market Share (2014-2019)
Table Amgen Inc Biosimilars Main Business and Markets Served
Table Biocon Biosimilars Production Sites and Area Served
Table Biocon Biosimilars Product Introduction, Application and Specification
Table Biocon Biosimilars Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Biocon Biosimilars Production Growth Rate (2014-2019)
Table Biocon Biosimilars Production Market Share (2014-2019)
Figure Biocon Biosimilars Revenue Market Share (2014-2019)
Table Biocon Biosimilars Main Business and Markets Served
Table Dr. Reddy’s Laboratories Biosimilars Production Sites and Area Served
Table Dr. Reddy’s Laboratories Biosimilars Product Introduction, Application and Specification
Table Dr. Reddy’s Laboratories Biosimilars Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Dr. Reddy’s Laboratories Biosimilars Production Growth Rate (2014-2019)
Table Dr. Reddy’s Laboratories Biosimilars Production Market Share (2014-2019)
Figure Dr. Reddy’s Laboratories Biosimilars Revenue Market Share (2014-2019)
Table Dr. Reddy’s Laboratories Biosimilars Main Business and Markets Served
Table F. Hoffmann-La Roche Biosimilars Production Sites and Area Served
Table F. Hoffmann-La Roche Biosimilars Product Introduction, Application and Specification
Table F. Hoffmann-La Roche Biosimilars Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Biosimilars Production Growth Rate (2014-2019)
Table F. Hoffmann-La Roche Biosimilars Production Market Share (2014-2019)
Figure F. Hoffmann-La Roche Biosimilars Revenue Market Share (2014-2019)
Table F. Hoffmann-La Roche Biosimilars Main Business and Markets Served
Table Celltrion Biosimilars Production Sites and Area Served
Table Celltrion Biosimilars Product Introduction, Application and Specification
Table Celltrion Biosimilars Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Celltrion Biosimilars Production Growth Rate (2014-2019)
Table Celltrion Biosimilars Production Market Share (2014-2019)
Figure Celltrion Biosimilars Revenue Market Share (2014-2019)
Table Celltrion Biosimilars Main Business and Markets Served
Table Samsung Bioepis Biosimilars Production Sites and Area Served
Table Samsung Bioepis Biosimilars Product Introduction, Application and Specification
Table Samsung Bioepis Biosimilars Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Samsung Bioepis Biosimilars Production Growth Rate (2014-2019)
Table Samsung Bioepis Biosimilars Production Market Share (2014-2019)
Figure Samsung Bioepis Biosimilars Revenue Market Share (2014-2019)
Table Samsung Bioepis Biosimilars Main Business and Markets Served
Figure Global Biosimilars Production (K MT) Growth Rate Forecast 2019-2025
Figure Global Biosimilars Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Biosimilars Sales Price (USD/MT) Forecast 2019-2025
Figure North America Biosimilars Production Growth Rate Forecast 2019-2025 (K MT)
Figure North America Biosimilars Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Biosimilars Production Growth Rate Forecast 2019-2025 (K MT)
Figure Europe Biosimilars Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Biosimilars Production Growth Rate Forecast 2019-2025 (K MT)
Figure China Biosimilars Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Biosimilars Production Growth Rate Forecast 2019-2025 (K MT)
Figure Japan Biosimilars Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Biosimilars Production Growth Rate Forecast 2019-2025 (K MT)
Figure Southeast Asia Biosimilars Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Biosimilars Production Growth Rate Forecast 2019-2025 (K MT)
Figure India Biosimilars Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K MT) of Biosimilars by Type (2019-2025)
Table Global Consumption (K MT) of Biosimilars by Application (2019-2025)
Table Biosimilars Distributors List
Table Biosimilars Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
バイオシミラー/フォローオンバイオロジクスの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Scope of the Report: This report studies the Biosimilars/follow-on-biologics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Biosimilars/follow-on-biologi…- G-CSFバイオシミラーの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein containing 174 amino acids with a molecular weight of about 20000. Scope of the Report: This report focuses on the G-CSF Biosimilars in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and …
- HGHバイオシミラーの世界市場予測 2023年：メーカー別、地域別、種類・用途別 HGH Biosimilars is DNA recombinant human growth hormone, which has the same function as human growth hormone. It can promote bone, visceral and whole body growth, promote protein synthesis, affect fat and mineral metabolism, and play a key role in human growth and development. Subcutaneous injection…
- 組換えペプチドのグローバル市場調査 2019年 The global Recombinant Peptides market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Recombinant Peptides volume and value at global level, regional level and company level. From a global perspective, th…
- 組換えペプチドのグローバル市場調査 2019年 The global Recombinant Peptides market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Recombinant Peptides volume and value at global level, regional level and company level. From a global perspective, th…